2019
DOI: 10.1136/dtb.2019.000006
|View full text |Cite
|
Sign up to set email alerts
|

Prescribing for pregnancy: managing prescribing for women with mental health diagnoses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…The preconception period is an opportunity to optimise and stabilise a woman’s medication and condition. In general, the aim is to use the lowest effective dose and monotherapy where possible 3. The results of previous studies on the effect of antidepressant exposure on neurodevelopmental disorders have largely been conflicting 4.…”
Section: Contextmentioning
confidence: 99%
“…The preconception period is an opportunity to optimise and stabilise a woman’s medication and condition. In general, the aim is to use the lowest effective dose and monotherapy where possible 3. The results of previous studies on the effect of antidepressant exposure on neurodevelopmental disorders have largely been conflicting 4.…”
Section: Contextmentioning
confidence: 99%
“…Prescribers and pregnant women must carefully consider the potential risks of antipsychotic treatment in pregnancy. A recent Drug and Therapeutics Bulletin review outlined principles for safe prescribing in pregnant women with a mental health diagnosis 4. These include optimising and stabilising medication and the mental health condition prior to conception, prescribing the lowest effective dose and using monotherapy, if possible, and advising women not to stop their medication without discussing it with an experienced practitioner.…”
Section: Contextmentioning
confidence: 99%
“…Safe and effective prescribing is an essential component of antenatal care. Prescribing in pregnancy requires additional knowledge and caution due to the potential for teratogenesis, altered pharmacokinetics, maternal concerns1 and potential for short and longer term harm to the fetus 2 3. Antenatal information4 provided to pregnant women states that most medications reach the fetus and all medication use should be discussed with health professionals.…”
Section: Introductionmentioning
confidence: 99%